ArticleAJOG global reports2025

Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial.

Vicki L Schnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.